Information Provided By: 
Fly News Breaks for July 17, 2015
AGN
Jul 17, 2015 | 06:39 EDT
RBC Capital downgraded Allergan to Outperform and maintained its $361 price target. The firm sees few catalysts and is less confident near-term in P&L upside, but has left estimates unchanged. RBC Capital said there are several important products subject to competitive threats that could pressure sentiment but said valuation remains attractive against solid mid-teens multi-year earnings growth.
News For AGN From the Last 2 Days
There are no results for your query AGN
